Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market

Philip J. Almeter, Eugene A. Hessel, Jonathan A. Labuhn, Peter E. Morris

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science